Patent ID: 11890375
Assignee: SUN PHARMA ADVANCED RESEARCH COMPANY LTD.
Field: Pharmaceuticals (Chemistry)
Classification: CPC A | IPC A

Claim 17:
18. A method of treating an inflammatory disorder of the eye, said method comprising administering twice-a-day, a clear aqueous solution comprising in an aqueous vehicle:
(a) about 0.04% w/v difluprednate,
(b) about 1.4% w/v polyvinyl alcohol or derivative thereof,
(c) about 0.025% w/v benzalkonium chloride; and
(d) about 5.0% w/v polyoxyl 35 castor oil;
(e) about 0.6% w/v boric acid;
(f) about 0.005% w/v polyhexamethylene biguanide;
(g) about 0.03% w/v N-lauroyl sarcosine or sodium salt thereof;
(h) about 0.05% w/v disodium edetate; and
(i) about 1.5% w/v glycerol;, into the eye of a person in need thereof.